DE69829236D1 - Zusammensetzungen enthaltendes biologisch aktives Silizium - Google Patents

Zusammensetzungen enthaltendes biologisch aktives Silizium

Info

Publication number
DE69829236D1
DE69829236D1 DE69829236T DE69829236T DE69829236D1 DE 69829236 D1 DE69829236 D1 DE 69829236D1 DE 69829236 T DE69829236 T DE 69829236T DE 69829236 T DE69829236 T DE 69829236T DE 69829236 D1 DE69829236 D1 DE 69829236D1
Authority
DE
Germany
Prior art keywords
composition containing
biologically active
active silicon
containing biologically
silicon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69829236T
Other languages
English (en)
Other versions
DE69829236T2 (de
Inventor
Marie-Christine Seguin
Jean Gueyne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69829236D1 publication Critical patent/DE69829236D1/de
Application granted granted Critical
Publication of DE69829236T2 publication Critical patent/DE69829236T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C07F9/4012—Esters of acyclic acids which can have further substituents on alkyl substituted by B, Si, P or a metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
DE69829236T 1997-03-24 1998-03-23 Zusammensetzungen enthaltendes biologisch aktives Silizium Expired - Fee Related DE69829236T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703793A FR2761075B1 (fr) 1997-03-24 1997-03-24 Nouveaux composes a base de silicium biologiquement actifs et leurs applications therapeutiques
FR9703793 1997-03-24

Publications (2)

Publication Number Publication Date
DE69829236D1 true DE69829236D1 (de) 2005-04-14
DE69829236T2 DE69829236T2 (de) 2006-02-02

Family

ID=9505261

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69829236T Expired - Fee Related DE69829236T2 (de) 1997-03-24 1998-03-23 Zusammensetzungen enthaltendes biologisch aktives Silizium

Country Status (12)

Country Link
US (1) US6001389A (de)
EP (1) EP0870504B1 (de)
JP (1) JPH10279484A (de)
AR (1) AR011998A1 (de)
AT (1) ATE290538T1 (de)
BR (2) BRPI9800956B8 (de)
CA (1) CA2234500C (de)
DE (1) DE69829236T2 (de)
DK (1) DK0870504T3 (de)
ES (1) ES2239384T3 (de)
FR (1) FR2761075B1 (de)
PT (1) PT870504E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2799758B1 (fr) 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation
ES2393101T3 (es) * 2001-08-29 2012-12-18 Ricardo A. P. De Carvalho Sistema implantable y sellable para la administración unidireccional de agentes terapéuticos a tejidos diana
US7595308B2 (en) * 2002-11-18 2009-09-29 Grenpharma Llc Compositions for treating and/or preventing diseases characterized by the presence of metal ions
EP1583765A4 (de) * 2002-11-18 2008-03-26 Grenpharma Llc Zusammensetzungen zur behandlung und/oder prävention von erkrankungen, die durch vorliegen von metallionencharakterisiert sind
WO2006047477A1 (en) * 2004-10-22 2006-05-04 Grenpharama Llc Compositions for treating and/or preventing diseases characterized by the presence of the metal ions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1090210B (de) * 1956-05-31 1960-10-06 Gen Electric Verfahren zur Herstellung von Phosphonsaeureesterreste enthaltenden Organosiliciumverbindungen
US3914416A (en) * 1966-12-23 1975-10-21 Exsymol Sa Certain monomethyl trisilanol mannuronate complexes for treating cellulitis
FR6871M (de) * 1966-12-23 1969-04-14
FR2610522B1 (fr) * 1987-02-06 1989-08-18 Gueyne Jean Produit therapeutique a base de derives organiques du silicium
JPH0532683A (ja) * 1991-07-29 1993-02-09 Sanwa Kagaku Kenkyusho Co Ltd 有機ゲルマニウム並びに有機珪素化合物、その製法及び用途
FR2725207B1 (fr) * 1994-09-30 1996-11-29 Exsymol Sa Composes a base de silicium biologiquement actifs, leurs applications therapeutiques et cosmetiques
FR2725208B1 (fr) * 1994-09-30 1996-11-29 Exsymol Sa Procede de preparation de composes de silicium biologiquement actifs sous forme concentree

Also Published As

Publication number Publication date
BR9800956A (pt) 2001-03-13
US6001389A (en) 1999-12-14
BRPI9800956B1 (pt) 2018-09-11
DK0870504T3 (da) 2005-07-18
PT870504E (pt) 2005-07-29
ES2239384T3 (es) 2005-09-16
JPH10279484A (ja) 1998-10-20
EP0870504A2 (de) 1998-10-14
AR011998A1 (es) 2000-09-13
FR2761075A1 (fr) 1998-09-25
DE69829236T2 (de) 2006-02-02
ATE290538T1 (de) 2005-03-15
EP0870504A3 (de) 2002-09-11
CA2234500A1 (fr) 1998-09-24
FR2761075B1 (fr) 1999-06-11
EP0870504B1 (de) 2005-03-09
BRPI9800956B8 (pt) 2021-05-25
CA2234500C (fr) 2009-08-25

Similar Documents

Publication Publication Date Title
PT853945E (pt) Formulacoes liquidas contendo gonadotrofina
ID22878A (id) Komposisi aktif secara terapi
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
DK1006792T3 (da) Landbrugskemisk sammensætning
NO20001631L (no) 2-metyl-tieno-benzodiazepin formulering
DE69839157D1 (de) Fullurene enthaltendes katherdersystem
FI955042A0 (fi) Syklosporiinia sisältävä jauhemainen koostumus
FI970741A (fi) Pinta-aktiiviset valmisteet
FI970742A0 (fi) Pinta-aktiiviset valmisteet
MA24473A1 (fr) Formulations
DE69807281D1 (de) Difluprednat enthaltende Zusammensetzungen
ID25508A (id) Komposisi dematologis
DE69826138D1 (de) Parfümzusammensetzung
DK1300129T3 (da) Implantathætteglas
DE69827744D1 (de) Polybuten-1 enthaltende polyolefinzusammensetzung
ID21009A (id) Komposisi untuk supositori
ATE357237T1 (de) Formulierungen enthaltend cefuroxim-axetil
PT975312E (pt) Composicoes contendo um antifungico e um fosfolipido
ID23250A (id) Komposisi paroksetin
ID21906A (id) Komposisi adesif
ID24677A (id) Kombinasi senyawa aktif fungisidal
ID29294A (id) Komposisi farmasi
DE69822559D1 (de) Siliconzusammensetzung
NO20016147L (no) Biologiske aktive materialer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Ref document number: 870504

Country of ref document: EP

Effective date: 20111001